Press releases | Finanzwire

Basculer en Français

11226	Companies
248944	Keywords
176742	Articles
134749	Press releases

Home
Press releases

PRESS RELEASE

published on 04/16/2026 at 07:34, 6 months 9 days ago

ONWARD Medical Successfully Raises over EUR 40 Million in Capital Increase
ONWARD Medical successfully raises over EUR 40 million in capital increase, with EUR 25.0M investment from EQT Life Sciences. Cash runway extended into Q1 2028

EQT Life Sciences Capital Increase Neurotechnology ONWARD Medical Spinal Cord Injuries
PRESS RELEASE

published on 04/16/2026 at 07:30, 6 months 9 days ago

Weak demand reflected in R. STAHL’s 2025 figures – Executive Board expects business to stabilize at a modest level in 2026
R. STAHL reports weak demand in 2025 with sales of €313.0 million, order intake down to €306.5 million. The Executive Board foresees a modest stabilizing in business for 2026 with sales between €285-300 million

R. STAHL Business Stability Weak Demand 2025 Figures NEXUS Program
PRESS RELEASE

published on 04/16/2026 at 07:30, 6 months 9 days ago

Inside Information / News release on accounts, results
Pernod Ricard reports stable organic net sales in Q3 FY26 amidst a volatile market. Improving momentum seen in total group volumes and strategic international brands. Focus on consumer trends and market expansion

Market Trends Volatility PERNOD RICARD Organic Net Sales Consumer Needs
PRESS RELEASE

published on 04/16/2026 at 07:30, 6 months 9 days ago

Kering:
Kering unveils ReconKering strategy to lead in luxury with emphasis on desirability, excellence, and Next Luxury. Houses' brand strategies focused on uniqueness and growth paths

Luxury Kering Brand Strategies ReconKering Desirability
PRESS RELEASE

published on 04/16/2026 at 07:30, 6 months 9 days ago

Inside Information / Other news releases
M&P reports strong Q1 2026 results with increased production and sales, active drilling programs in Gabon, Tanzania, Colombia, and Venezuela, and positive financial position for future growth opportunities

Sales Drilling Production M&P Q1 2026
PRESS RELEASE

published on 04/16/2026 at 07:00, 6 months 10 days ago

NFON confirms preliminary results for 2025 – profitability improves, AI solutions drive business growth
NFON AG confirms preliminary financial results for 2025, reporting improved profitability and business growth driven by AI solutions. Full audited report available on the company's website

Business Growth AI Solutions Preliminary Results NFON AG 2025
PRESS RELEASE

published on 04/16/2026 at 07:00, 6 months 10 days ago

FUCHS presents its new strategy – “FOCUS TO WIN” on the path to its 100th anniversary
FUCHS presents its new strategy 'FOCUS TO WIN' on the path to its 100th anniversary, focusing on Growth, Sustainability, and People. Financial targets up to 2031 set

Sustainability Strategy Growth Anniversary FUCHS
PRESS RELEASE

published on 04/16/2026 at 07:00, 6 months 10 days ago

BioVersys announces first patient first visit in HABP/VABP pivotal Phase 3 RIV-TARGET trial of BV100
BioVersys AG announces the first patient first visit in the HABP/VABP pivotal Phase 3 RIV-TARGET trial of BV100, an anti-infective agent for CRAB infections

Phase 3 BioVersys AG BV100 CRAB Infections RIV-TARGET Trial
PRESS RELEASE

published on 04/16/2026 at 07:00, 6 months 10 days ago

DocMorris publishes invitation to the Annual General Meeting
DocMorris publishes invitation to the Annual General Meeting, proposing a partial board renewal and warning against a hostile takeover attempt by a Polish investor. Shareholders urged to protect their investment

Annual General Meeting Shareholders DocMorris Hostile Takeover Board Renewal
PRESS RELEASE

published on 04/16/2026 at 06:58, 6 months 10 days ago

DocMorris achieves strong revenue growth in Q1 2026 – on track for EBITDA break-even
DocMorris achieves strong revenue growth in Q1 2026, with an external revenue increase of 10.7%. On track for EBITDA break-even. CEO and CFO express optimism for reaching financial goals

Revenue Growth DocMorris EBITDA Break-even Financial Goals Q1 2026

Accesswire

Published on 10/24/2026 at 00:25, 2 days 6 hours ago

Caldwell Announces Sale of IQTalent
Published on 10/24/2026 at 00:04, 2 days 7 hours ago

Sparta Capital Ltd. Provides Corporate Update on Reinstatement Review, Financial Statement Corrections and Governance Matters
Published on 10/23/2026 at 23:30, 2 days 7 hours ago

Algo Grande Commissions Independent NI 43-101 Update to Capture First Year of Progress at Adelita
Published on 10/23/2026 at 21:55, 2 days 9 hours ago

Apex Closes Offering and Completes NASDAQ Listing
Published on 10/23/2026 at 16:00, 2 days 15 hours ago

Leggett Dynamics's Mid-Class Massage System Wins Gasgoo's Best Technical Practice Award

View all ACCESSWIRE

EQS Group

Published on 10/26/2026 at 07:00, 14 minutes ago

Swiss Prime Site defines strategic priorities and Ambition 2030 and raises 2026 guidance
Published on 10/26/2026 at 07:00, 15 minutes ago

Decisive action to improve performance in Germany; Second French bolt-on acquisition completed; Year end 2026 guidance
Published on 10/26/2026 at 06:45, 29 minutes ago

HBM Portfolio Company Lycia Therapeutics Raises USD 317.5 Million in Nasdaq IPO and Delivers Strong Market Debut
Published on 10/26/2026 at 06:45, 29 minutes ago

AOT Engages Over 50 Airlines and Airport at Routes World 2026 to Boost Thailand’s Global Connectivity
Published on 10/26/2026 at 02:05, 5 hours 9 minutes ago

Tin Men Capital leads US$7.4M Series A for Vision AI startup Ailytics to expand across APAC, US and Gulf

Les Echos

Published on 10/23/2026 at 20:33, 2 days 10 hours ago

Disclosure of transactions in own shares from October 19 to October 23, 2026
Published on 10/23/2026 at 17:45, 2 days 13 hours ago

Imerys-10-2026-information-share-capital-and-voting-rights-as-of-30-September-2026
Published on 10/23/2026 at 07:00, 3 days ago

Safran reports third quarter 2026 revenue
Published on 10/22/2026 at 18:00, 3 days 13 hours ago

THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 3 days 13 hours ago

bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics

View all LES ECHOS COMFI WIRE